Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Glass Filters to Separate Tumor Cells in Blood Tests Can Speed Up Cancer Diagnosis

By LabMedica International staff writers
Posted on 04 May 2023

Early diagnosis is crucial for effective cancer treatment, as even brief delays can impact patient health and longevity. One promising approach involves detecting circulating tumor cells (CTCs) and cancer-associated fibroblasts (CAFs) released by tumors into blood samples. Analyzing these cells can provide direct information about cancer and predict disease progression in its early stages. However, the number of CTCs in cancer patients' blood is extremely low, necessitating improvements in capture and culture efficiency. Although glass is commonly used for cell culturing in laboratories, its application in CTC culturing has been underexplored. Researchers have now identified the optimal dimensions of glass filters for capturing CTCs and CAFs, demonstrating their ability to detect cells from lung cancer patients.

Researchers from Nagoya University (Nagoya, Japan) employed a unique method to visualize and capture cells on glass filters, which could lead to more efficient tumor cell culturing and improved cancer detection. They developed glass filters with various shapes and dimensions to determine which best captured CTCs and CAFs from lung cancer patients. Additionally, they created a system called FROG-CHIP to visualize the CTCs and CAFs captured on the glass filters. The researchers discovered that the most effective patterns for capturing CTCs, while allowing white blood cells to pass through, consisted of a circular pattern with a pitch of 20 micrometers and a diameter of eight micrometers. These dimensions provided high capture efficiency without retaining a significant number of white blood cells.

"These results suggest that our glass filters are useful as a tool for the early diagnosis of tumors," said Professor Tanaka of the Center for Low-Temperature Plasma Sciences. "Our findings would be useful at hospitals, clinics, and diagnostic testing companies to speed up cancer diagnosis."

Related Links:
Nagoya University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.